Vmbook Online ordering

Repligen Corporation

Sure, I can help you with that.

Repligen Corporation is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol RGEN. Repligen is a biotechnology company that focuses on developing and commercializing bioprocessing technologies used in the manufacturing of biologics, such as monoclonal antibodies and recombinant proteins.

Here are some general information and statistics about Repligen Corporation:

* Founded: 1981

* Headquarters: Waltham, Massachusetts, USA

* Industry: Biotechnology

* Sector: Healthcare

* NASDAQ ticker symbol: RGEN

* Market capitalization: Approximately $2.4 billion (as of March 11, 2023)

* Number of employees: 180 (as of December 31, 2022)

* Revenue (2022): $186.7 million

* Net income (2022): $36.7 million

* Earnings per share (2022): $0.56

* P/E ratio (TTM): 28.56

Repligen's main product is the OptiChrom column, which is a disposable chromatography column used in bioprocessing. The company's customer base includes a wide range of biotechnology and pharmaceutical companies, such as Pfizer, Amgen, and Biogen. Repligen has also developed a line of products for cell culture media and buffers, and it provides process development and optimization services for its customers.

Repligen Corporation has been publicly traded since 1985 and has consistently demonstrated revenue growth over the years. In recent times, the company has made efforts to expand its product offerings and geographic presence through strategic acquisitions and collaborations.